These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 30367383)
1. Fluorescence-guided surgery with aminolevulinic acid for low-grade gliomas. Hendricks BK; Sanai N; Stummer W J Neurooncol; 2019 Jan; 141(1):13-18. PubMed ID: 30367383 [TBL] [Abstract][Full Text] [Related]
2. Fluorescence-guided surgery in high grade gliomas using an exoscope system. Belloch JP; Rovira V; Llácer JL; Riesgo PA; Cremades A Acta Neurochir (Wien); 2014 Apr; 156(4):653-60. PubMed ID: 24468884 [TBL] [Abstract][Full Text] [Related]
3. Intra-operative visualization of brain tumors with 5-aminolevulinic acid-induced fluorescence. Widhalm G Clin Neuropathol; 2014; 33(4):260-78. PubMed ID: 24986206 [TBL] [Abstract][Full Text] [Related]
4. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery. Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489 [TBL] [Abstract][Full Text] [Related]
5. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963 [TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Surgery of High-Grade Gliomas: A Systematic Review. Guyotat J; Pallud J; Armoiry X; Pavlov V; Metellus P Adv Tech Stand Neurosurg; 2016; (43):61-90. PubMed ID: 26508406 [TBL] [Abstract][Full Text] [Related]
7. What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas? Hadjipanayis CG; Widhalm G; Stummer W Neurosurgery; 2015 Nov; 77(5):663-73. PubMed ID: 26308630 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients. Hickmann AK; Nadji-Ohl M; Hopf NJ J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106 [TBL] [Abstract][Full Text] [Related]
9. Following the light in glioma surgery: a comparison of sodium fluorescein and 5-aminolevulinic acid as surgical adjuncts in glioma resection. Navarro-Bonnet J; Suarez-Meade P; Brown DA; Chaichana KL; Quinones-Hinojosa A J Neurosurg Sci; 2019 Dec; 63(6):633-647. PubMed ID: 31961116 [TBL] [Abstract][Full Text] [Related]
10. Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies. Li Y; Rey-Dios R; Roberts DW; Valdés PA; Cohen-Gadol AA World Neurosurg; 2014; 82(1-2):175-85. PubMed ID: 23851210 [TBL] [Abstract][Full Text] [Related]
11. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases. Marbacher S; Klinger E; Schwyzer L; Fischer I; Nevzati E; Diepers M; Roelcke U; Fathi AR; Coluccia D; Fandino J Neurosurg Focus; 2014 Feb; 36(2):E10. PubMed ID: 24484248 [TBL] [Abstract][Full Text] [Related]
12. 5-ALA fluorescence on tumors different from malignant gliomas. Review of the literature and our experience. Boschi A; Della Puppa A J Neurosurg Sci; 2019 Dec; 63(6):661-669. PubMed ID: 31355622 [TBL] [Abstract][Full Text] [Related]
13. Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. Sanai N; Snyder LA; Honea NJ; Coons SW; Eschbacher JM; Smith KA; Spetzler RF J Neurosurg; 2011 Oct; 115(4):740-8. PubMed ID: 21761971 [TBL] [Abstract][Full Text] [Related]
14. [Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant gliomas--a new treatment modality]. Cortnum S; Laursen R Ugeskr Laeger; 2013 Feb; 175(9):570-3. PubMed ID: 23608006 [TBL] [Abstract][Full Text] [Related]
15. Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. Tonn JC; Stummer W Clin Neurosurg; 2008; 55():20-6. PubMed ID: 19248665 [No Abstract] [Full Text] [Related]
16. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience. Haider SA; Lim S; Kalkanis SN; Lee IY J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501 [TBL] [Abstract][Full Text] [Related]
17. Insular gliomas and the role of intraoperative assistive technologies: Results from a volumetry-based retrospective cohort. Barbosa BJ; Dimostheni A; Teixeira MJ; Tatagiba M; Lepski G Clin Neurol Neurosurg; 2016 Oct; 149():104-10. PubMed ID: 27509592 [TBL] [Abstract][Full Text] [Related]
18. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review. Broekx S; Weyns F; De Vleeschouwer S Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151 [TBL] [Abstract][Full Text] [Related]
19. 5-Aminolevulinic Acid: Pitfalls of Fluorescence-guided Resection for Malignant Gliomas and Application for Malignant Glioma Therapy. Yamamoto J; Kitagawa T; Miyaoka R; Suzuki K; Takamatsu S; Saito T; Nakano Y J UOEH; 2020; 42(1):27-34. PubMed ID: 32213740 [TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas. Chohan MO; Berger MS J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]